Enalapril and Prazosin Interaction

Drug interaction information between Enalapril and Prazosin.

Enalapril and Prazosin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Enalapril and Prazosin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Enalapril

ACE Inhibitor

Drug B

Prazosin

Alpha-1 Blocker

How They Interact

Both drugs are used to lower blood pressure, but studies show they do not cause harmful interactions when taken together.

FDA Label Information

Other Cardiovascular Agents Enalapril maleate has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.

Frequently Asked Questions

What SPL severity band is on file for Enalapril + Prazosin?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Enalapril has 16 labeled pairs on file vs Prazosin's 11. In the minor band specifically: Enalapril has 15 (also Spironolactone, Hydralazine, Lithium, Methyldopa); Prazosin has 11 (also Allopurinol, Aspirin, Diazepam, Digoxin).

What mechanism field is on file for Enalapril and Prazosin?

Both drugs are used to lower blood pressure, but studies show they do not cause harmful interactions when taken together.

Enalapril carries more major-labeled pairs than Prazosin

SPL source-record counts only. This page's band is minor · classes on file: Enalapril (ACE Inhibitor); Prazosin (Alpha-1 Blocker).

Enalapril has 1 major-labeled pair vs Prazosin's 0. This page itself is in the minor band, not the major band.

Enalapril

1 major · 0 moderate · 15 minor · 16 total

Prazosin

0 major · 0 moderate · 11 minor · 11 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.